motherlodetv.net
NexGen Energy Ltd. (“NexGen” or the “Company”) (TSX: NXE, NYSE MKT: NXE) is pleased to report radioactivity results for an additional forty holes comprising 18,166.5 m from the Company’s Feasibility stage drilling program at our 100% owned, Rook I property in the Athabasca Basin, Saskatchewan.
Over at North of 60 Mining News there is an excellent article on Golden Predator’s (V.GPY) efforts to bring the Brewery Creek mine back into operation in the Yukon.
Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Aben or the Company”) announces the commencement of diamond drilling at the Forrest Kerr Gold Project in BC’s Golden Triangle and the completion of the 2019 drill program at the Justin Gold Project in the Yukon. The Company is planning to start with another 5000-meter drill program at Forrest Kerr this year that can be expanded to 10,000 meters as results dictate. Aben Resources is well funded with over $5 million in the treasury.
Almost exactly two years ago I was on the Yukon Mining Alliance Media Tour and went to the Victoria Gold (V.VIT) Dublin Gulch Eagle Mine project, 80 bumpy kilometres from Mayo, Yukon. There, VP Exploration, Paul Gray took us on a tour of the proposed mine site. There were some roads bulldozed out of the bush, drill collars, a large camp which was somewhat empty and a vision. John McConnell’s vision of a 200,000 ounce per year gold mine.
I am just finishing writing up my interview with John McConnell, CEO of Victoria Gold (VIT). As an aside in this interview, I complimented John on the excellent update videos he has been posting as the Eagle Mine goes forward. I kidded him about the fact that “the explosions” were the best part.
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company (the “Parties”), announced today that, on June 28, 2019, they finalized the acquisition by FSD Pharma of all of the issued and outstanding securities of Prismic (the “Transaction”). Pursuant to the terms of a previously-announced securities exchange Agreement, FSD Pharma has acquired all outstanding common and preferred shares of Prismic for an aggregate purchase price of approximately US$17.5 million (CAD$23.4 million based on an exchange rate of US$1 to CAD$1.3349), satisfied by the issuance of approximately 102.7 million Class B subordinate voting shares in the capital of FSD Pharma (each, an “FSD Share”) at a deemed price of CAD$0.2275 (US$0.1704) per FSD Share. In addition, FSD Pharma has agreed to assume approximately US$3.05 million of outstanding Prismic long- and short-term liabilities. All of the outstanding Prismic stock options and warrants have been converted into options and warrants to purchase FSD shares, with the number and exercise price of such securities having been adjusted in accordance with the exchange ratio under the Agreement.
World Class Extractions Inc. (the “Company” or “World Class”) (CSE: PUMP) is pleased to announce that, effective immediately, it has appointed Anthony Durkacz as Chair of the Board of Directors. Mr. Durkacz was recently appointed to the Company’s Board of Directors in conjunction with its recent merger with Quadron Cannatech Corporation.
Whether you think CO2 driven climate change is a “climate emergency” or a complete crock, the fact is that there is a lot of money looking for practical solutions to the problem of CO2. A lot of that money has gone into things like solar and wind power which, proponents say, will reduce emissions over time by generating electricity without burning fossil fuels. But what about the CO2 which has already been emitted? While climate scientists have been steadily revising temperature sensitivity estimates downward, there is a terrific political momentum behind the idea that CO2 and temperature are linked and that, despite a lack of scientific evidence, that link causes everything from sea level rise to rain “events”.
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. (“FV Pharma”) has received its Full Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license is effective as of June 21, 2019.
White Gold Corp’s (V.WGO) exploration and geological team led by legendary Yukon prospector, Shawn Ryan, and quarterbacked by VP Exploration, Jodie Gibson, is already in the field and as CEO David D’Onofrio said in a recent interview with MotherlodeTV: “This season is our most exciting yet and we are well underway.”